• 1
    Anonymous: Cranbury , NJ : Wallace Laboratories, August 1, 1994.
  • 2
    Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agrunulocytosis and aplastic anemia. New York : Oxford University Press, 1991.
  • 3
    Kaufman DW, Kelly JP, Johmnes CB, et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993;82:27148.
  • 4
    Issaragrisil S, Kaufman DW, Anderson T, et al. Low drug attributability of aplastic anemia in Thailand. Blood 1997;89:40349.
  • 5
    Anonymous. Walsh America data. Cranbury , NJ , Wallace Laboratories, 1996.
  • 6
    Hart RG, Easton JD. Carbamazepine and hematologic monitoring. Ann Neurol 1982;11:30912.
  • 7
    Pellock JM. Carbamazepine side effects in children and adults. Epilepsiu 1987;28(suppl 3):S364.
  • 8
    Kaufman DW, Kelly JP, Jurgelon J, et al. Drugs in the etiology of agranulocytosis and aplastic anemia. Eur J Huemato/ 1996;57 (suppl 60):2330.
  • 9
    Roujeau J-C, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:16007.